Feliciani, Claudio
 Distribuzione geografica
Continente #
EU - Europa 1.711
NA - Nord America 1.667
AS - Asia 582
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
OC - Oceania 3
Totale 3.975
Nazione #
US - Stati Uniti d'America 1.654
DE - Germania 699
SE - Svezia 278
CN - Cina 269
UA - Ucraina 246
SG - Singapore 162
IT - Italia 121
IE - Irlanda 84
FR - Francia 83
GB - Regno Unito 64
FI - Finlandia 62
IN - India 54
ID - Indonesia 51
RU - Federazione Russa 42
JP - Giappone 18
BE - Belgio 14
TR - Turchia 14
CA - Canada 9
IR - Iran 6
NL - Olanda 6
PL - Polonia 5
EU - Europa 4
MX - Messico 4
AU - Australia 3
CI - Costa d'Avorio 2
HK - Hong Kong 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
GR - Grecia 1
IL - Israele 1
LT - Lituania 1
NO - Norvegia 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 3.975
Città #
Chandler 372
Jacksonville 120
San Mateo 115
Ashburn 111
Singapore 102
Nanjing 83
Dublin 78
Wilmington 75
Woodbridge 60
Jakarta 49
Nürnberg 44
Ann Arbor 41
Houston 40
Lawrence 37
New York 36
Redmond 34
Dearborn 32
Moscow 30
Milan 27
Redwood City 26
Nanchang 25
Mountain View 23
Seattle 22
Cattolica 21
Tianjin 18
Marseille 17
Scottsdale 16
Boston 15
Beijing 14
Bremen 14
Munich 14
Princeton 14
Izmir 13
Shenyang 13
Boardman 12
Brussels 12
Fairfield 12
Hebei 12
Helsinki 12
Kunming 12
Hangzhou 11
Leawood 11
Los Angeles 10
Zhengzhou 9
Norwalk 8
Rome 8
Shanghai 8
Cambridge 7
Jiaxing 7
University Park 7
Changsha 6
Fremont 6
Lancaster 6
Ypsilanti 6
Lanzhou 5
Millbury 5
Amsterdam 4
Guangzhou 4
Hefei 4
Kish 4
Kraków 4
London 4
Ottawa 4
Andover 3
Bari 3
Bologna 3
Indiana 3
Monterrey 3
Montréal 3
Philadelphia 3
Renton 3
Sacramento 3
San Francisco 3
Teramo 3
Abidjan 2
Augusta 2
Block 2
Centreville 2
Changshahsien 2
Costa Mesa 2
Falls Church 2
Frankfurt am Main 2
Fuzhou 2
Hong Kong 2
Jeddah 2
Monmouth Junction 2
Mumbai 2
Pomezia 2
Porto Torres 2
Pune 2
Saint Petersburg 2
San Diego 2
Santa Clara 2
Simi Valley 2
South Tangerang 2
Southend 2
Sydney 2
Tokyo 2
Toronto 2
Alghero 1
Totale 2.055
Nome #
Ocular mucous membrane pemphigoid after Lyell syndrome: occasional finding or predisposing event? 164
Serum interleukin-18 in children with Henoch-Schonlein purpura: a promising marker of disease activity? 126
Updated review of the pathogenesis and management of Merkel cell carcinoma 125
The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis. 124
Angiokeratoma: decision-making aid for the diagnosis of Fabry disease 117
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 115
Linear atrophoderma of Moulin 113
Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B 113
Systemic complications of esophageal lichen planus 111
Updated review of the pathogenesis and management of Merkel cell carcinoma 109
Exacerbation of pemphigus after influenza vaccination. 108
A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris? 105
Occupational contact dermatitis from carbapenems 105
Circumscribed pityriasis rubra pilaris type IV 102
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 101
Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases 96
Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study 96
Small lymphocytic lymphoma in a patient with Fabry disease 86
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 82
IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses 81
Vascular Endothelial Growth Factor (VEGF-a) in Fabry disease: Association with cutaneous and systemic manifestations with vascular involvement 81
Acquired Epidermodysplasia Verruciformis: A Comprehensive Review and a Proposal for Treatment 81
Small lymphocytic lymphoma in a patient with Fabry disease 81
Paraneoplastic acrokeratosis (Bazex Syndrome) in lung cancer 80
The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis 80
Adult self-healing papular mucinosis on genital skin 79
Alteration of cholinergic system in keratinocytes cells produces acantholysis: a possible use of cholinergic drugs in pemphigus vulgaris 79
Cerebral Hemorrhage in a Paucisymptomatic Young Patient with Fabry Disease 79
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 76
Dyshidrosiform pemphigoid: a well-defined clinical entity? 75
Dermatological signs during inflammatory bowel diseases 71
Modelling the resource implications of managing adults with Fabry disease in Italy 70
Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations 68
Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors 66
Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis 65
Fabry disease: a review of current management strategies 63
Dyshidrosiform pemphigoid: a well-defined clinical entity? 62
Psoriatic Pseudobalanitis Circinata as a Post-Viral Koebner Phenomenon 62
Mutation identification of Fabry disease in families with other lysosomal storage disorders 62
Early-onset basal cell carcinoma in a case of Ivemark syndrome 54
Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis 54
Fabry disease: a review of current management strategies 51
Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS) 50
Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases 39
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data 38
Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS) 38
IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses 37
Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey 37
Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey 37
Totale 3.994
Categoria #
all - tutte 16.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020315 0 0 0 0 0 41 53 16 28 20 93 64
2020/2021444 8 50 5 50 58 33 68 21 59 19 68 5
2021/2022431 50 50 12 16 26 17 5 86 11 20 57 81
2022/2023918 134 137 85 137 90 104 31 68 108 4 17 3
2023/2024349 25 115 5 25 6 49 15 6 2 15 44 42
2024/2025229 23 22 58 61 50 15 0 0 0 0 0 0
Totale 3.994